Načítá se...
Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patients
BACKGROUND: Interleukin 36 (IL-36), as a gradually recognized cytokine, is involved in the occurrence and evolution of autoimmune diseases. Nevertheless, the relationship between myasthenia gravis (MG) and IL-36 is rarely reported. METHODS: We evaluated the serum levels of IL-36 (IL-36α, IL-36β and...
Uloženo v:
| Vydáno v: | BMC Neurol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436949/ https://ncbi.nlm.nih.gov/pubmed/32814555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-020-01885-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|